The mechanism of bioactivation and antigen formation of amodiaquine in the rat.

Article Details

Citation
Copy to clipboard

Harrison AC, Kitteringham NR, Clarke JB, Park BK

The mechanism of bioactivation and antigen formation of amodiaquine in the rat.

Biochem Pharmacol. 1992 Apr 1;43(7):1421-30.

PubMed ID
1567466 [ View in PubMed
]
Abstract

A glutathione conjugate of amodiaquine has been isolated and characterized from rat bile after administration of [14C]amodiaquine (50 mumol/kg, 5.0 muCi/rat) to anaesthetized male Wistar rats. Thioether conjugates of amodiaquine in rat bile accounted for a total of 12% of the dose, 5 hr after administration of the drug. In addition, 1% of the dose remained in the liver covalently bound to tissue proteins after 5 hr. These findings provide direct evidence that a chemically reactive metabolite, amodiaquine quinoneimine, has been formed from the drug in vivo. A second major metabolite, desethylamodiaquine, accounting for 14% of the given dose, was present in the liver after 5 hr. Enzyme inhibition studies with ketoconazole-pretreated rats showed that both amodiaquine quinoneimine and desethylamodiaquine formation can be catalysed by cytochrome P450. The demonstration that amodiaquine readily and extensively forms a metabolite in vivo, with strong reactivity towards protein and non-protein thiol groups, may help to explain the idiosyncratic toxicity observed in man.

DrugBank Data that Cites this Article

Drugs